4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-16-034104
Chief Financial Officer sold 3,900 shares at $28.19 ($109,955)
- Chief Financial Officer acquired 3,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Viret Jean-Frederic Chief Financial Officer | 2016-11-18 | Option exercise | +3,900 | $13.50 | $52,650 | 6,225 | D: show line 1 in the form |
| Viret Jean-Frederic Chief Financial Officer | 2016-11-18 | Sale | −3,900 | $28.19 | $109,955 | 2,325 | D: show line 2 in the form |
| Open-market sales · 3,900 sh · avg $28.19 · $109,955 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Viret Jean-Frederic Chief Financial Officer | 2016-11-18 | Option exercise · Stock Option (right to buy) | −3,900 | 120,948 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…